Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Polymerized insoluble bee venom

R Patterson, I M Suszko, S Hendrix

The Journal of Allergy and Clinical Immunology

|December 1, 1980

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Human leucocyte antigens (HLA) and trimellitic anhydride (TMA) immunological lung disease.

Respiratory medicine·2000

Same author

Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases.

Allergy and asthma proceedings·2000

Same author

Review of trimellitic anhydride (TMA) induced respiratory response.

Allergy and asthma proceedings·1997

Same author

Bean bag allergy revisited: a case of allergy to inhaled soybean dust.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·1996

Same author

Induction of type I hypersensitivity in guinea pigs after inhalation of phthalic anhydride.

The Journal of allergy and clinical immunology·1994

Same author

Evolution of patient care, education, and research in asthma by one academic team of investigators over 35 years: the Northwestern University Medical School Division of Allergy-Immunology experience (Part Two).

Allergy proceedings : the official journal of regional and state allergy societies·1994

Same journal

Corrigendum.

The Journal of allergy and clinical immunology·2026

Same journal

Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis.

The Journal of allergy and clinical immunology·2026

Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026

Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026

Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026

Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026

See all related articles

Polymerized insoluble bee venom (PIBV) was developed to reduce allergen spread after injection. This novel bee venom polymer demonstrated reduced dissemination and induced antibody formation in rabbits, suggesting potential for human immunotherapy.

Area of Science:

Immunology
Polymer Chemistry
Allergen Immunotherapy

Background:

Honeybee venom allergens can cause adverse reactions.
Developing safer delivery methods for allergens is crucial for immunotherapy.

Purpose of the Study:

To develop and characterize polymerized insoluble bee venom (PIBV).
To evaluate the physical and immunologic properties of PIBV for potential human use.

Main Methods:

Honeybee venom allergens were polymerized using a novel process.
125I-labeled phospholipase A (PL-A) was incorporated into PIBV.
PIBV was injected into rabbits to assess antibody formation.
Rabbit antisera were tested for binding to PL-A.

Main Results:

Related Experiment Videos

PIBV demonstrated reduced dissemination of PL-A from injection sites.
Approximately 90% of PL-A was incorporated into PIBV.
PIBV injection induced precipitating antibody formation in all rabbits.
Rabbit antisera showed specific binding to PL-A.

Conclusions:

PIBV is a stable, insoluble polymer incorporating bee venom allergens.
PIBV exhibits reduced allergen dissemination and induces a specific immune response.
These characteristics suggest PIBV's potential as a safer alternative for bee venom immunotherapy.